E coli cattle vaccine
From WikiCover
On August 23, 2007, Bioniche Life Sciences announced that the first permit has been issued for its E. coli O157:H7 cattle vaccine, and that the first order of vaccine has been shipped to that customer.
The vaccine will be used for the reduction of shedding of E. coli bacteria in cattle. Shed bacteria can contaminate food, water and the environment. Human exposures to this pathogen result in an estimated 100,000 cases of illness per year in North America. Use of the vaccine should reduce the amounts of bacteria in cattle and the related incidence of human disease.
The vaccine remains under review by The Canadian Food Inspection Agency (CFIA) and The United States Department of Agriculture (USDA). Bioniche is producting the E coli cattle vaccine at its Belleville, Ontario facility. This supply is now being provided to veterinarians requesting vaccine under the Canadian Permit to Release regulations. Bioniche will continue to scale up as full domestic and international approvals are received. Until such approvals are received, all vaccine will be shipped to Canadian veterinarians as permit requests are received and approved by the CFIA.